James Mulay serves as Executive at Fulgent Genetics, Inc., where they oversee executive responsibilities. Since joining the company, James Mulay has executed 15 insider transactions totaling $2.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 9, 2025 involved exercising options for 5,903 shares valued at $22.0K.
James Mulay currently holds 5,903 shares of Fulgent Genetics, Inc. (FLGT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Mulay has been a net seller of FLGT stock. They have purchased $0 and sold $2.5M worth of shares.
James Mulay's most recent insider trade was on Oct 9, 2025, when they sold 5,903 shares at $3.72 per share.
Get notified when new Form 4 filings are submitted
| $43.99 |
| Discretionary |
| Sep 29, 2025 | CGON | $499.9K | Sale | 12,755 | $39.19 | Discretionary |
| Sep 29, 2025 | CGON | $23.2K | Option Exercise | 12,755 | $1.82 | Discretionary |
| Sep 19, 2025 | CGON | $139.4K | Sale | 3,574 | $38.99 | Discretionary |
| Sep 19, 2025 | CGON | $6.5K | Option Exercise | 3,574 | $1.82 | Discretionary |
| Sep 18, 2025 | CGON | $745.6K | Sale | 19,112 | $39.01 | Discretionary |
| Sep 18, 2025 | CGON | $34.8K | Option Exercise | 19,112 | $1.82 | Discretionary |
| Sep 5, 2025 | CGON | $376.1K | Sale | 12,342 | $30.47 | Discretionary |
| Sep 5, 2025 | CGON | $128.7K | Sale | 4,095 | $31.42 | Discretionary |
| Sep 5, 2025 | CGON | $243.7K | Sale | 7,465 | $32.64 | Discretionary |
| Sep 5, 2025 | CGON | $16.2K | Option Exercise | 27,015 | $0.60 | Discretionary |
| Sep 5, 2025 | CGON | $103.4K | Sale | 3,113 | $33.22 | Discretionary |
| May 16, 2017 | FLGT | $0 | Award | 2,000 | $N/A | Discretionary |
| Oct 26, 2016 | FLGT | $0 | Award | 8,000 | $N/A | Discretionary |